DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results

Go back to DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results

DiaMedica Therapeutics Inc. (DMAC) Tops Q3 EPS by 1c

November 13, 2023 4:29 PM EST

DiaMedica Therapeutics Inc. (NASDAQ: DMAC) reported Q3 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13).

For earnings history and earnings-related data on DiaMedica Therapeutics Inc. (DMAC) click here.

... More